{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Earth City",
      "state": "MO",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "66838",
      "recalling_firm": "Forest Pharmaceuticals Inc",
      "address_1": "13600 Shoreline Dr",
      "address_2": "",
      "postal_code": "63045",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "recall_number": "D-1063-2014",
      "product_description": "Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045, NDC 0456-3407-33",
      "product_quantity": "156 bottles",
      "reason_for_recall": "Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.",
      "recall_initiation_date": "20131113",
      "center_classification_date": "20140204",
      "termination_date": "20140507",
      "report_date": "20140212",
      "code_info": "Lot 1111291 Exp. 02/16",
      "more_code_info": ""
    }
  ]
}